Skip to main navigation Skip to search Skip to main content

Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee

  • Aart J. van der Molen*
  • , Annick A. J. M. van de Ven
  • , Francisco Vega
  • , Ilona A. Dekkers
  • , Remy W. F. Geenen
  • , Marie-France Bellin
  • , Michele Bertolotto
  • , Torkel B. Brismar
  • , Olivier Clément
  • , Jean-Michel Correas
  • , Katerina Deike
  • , Gertraud Heinz
  • , Andreas H. Mahnken
  • , Carlo A. Mallio
  • , Carlo C. Quattrocchi
  • , Alexander Radbruch
  • , Peter Reimer
  • , Giles Roditi
  • , Laura Romanini
  • , Carmen Sebastià
  • Fulvio Stacul
*Corresponding author for this work
  • Leiden University
  • University of Groningen
  • Hospital Universitario de la Princesa
  • Amsterdam UMC - University of Amsterdam
  • North West Hospital Group
  • Université Paris-Saclay
  • University of Trieste
  • Karolinska Institutet
  • Hôpital européen Georges Pompidou
  • Université Paris Cité
  • University of Bonn
  • Massachusetts General Hospital
  • Landesklinikum St Pölten
  • University of Marburg
  • Campus Bio-Medico University Hospital Foundation
  • University of Trento
  • Klinikum Karlsruhe
  • Glasgow Royal Infirmary
  • ASST Cremona
  • Hospital Clinic de Barcelona
  • Ospedale Maggiore

Research output: Contribution to journalReview articleAcademicpeer-review

14 Downloads (Pure)

Abstract

Abstract: Hypersensitivity reactions to contrast media are infrequent and can occur either within the first 60 min following their intravascular administration (immediate reactions) or at a later time point (non-immediate reactions). Most hypersensitivity reactions are mild or moderate, while severe reactions are rare (less than 1 in every 10,000 administrations). After any moderate or severe immediate adverse reaction, serum tryptase must be measured within 1–4 h from the onset of symptoms and at least 24 h after symptoms have disappeared to confirm a hypersensitivity reaction. At least for all moderate-to-severe hypersensitivity reactions, the patient should be referred to a drug allergy specialist for an allergy evaluation with a panel of contrast media, and optionally, all hypersensitivity reactions when local drug allergy specialist capacity allows. Selecting an alternative contrast medium based on practical experience is challenging due to its high and variable cross-reactivity; therefore, the best option is to choose an alternative based on the results of an allergy evaluation. This approach is safer and more effective than premedication for preventing recurrent hypersensitivity reactions. Key Points: Question What is the optimal strategy in clinical practice to prevent recurrent hypersensitivity reactions in adults who previously experienced a hypersensitivity reaction to contrast media? Findings Serum tryptase should be measured within 1–4 h after a moderate or severe reaction, and at least all moderate or severe hypersensitivity reactions should be referred to an allergologist. Clinical relevance Management strategies should be adapted to the type and severity of the reaction, as well as the urgency of required re-administration. Changing from the culprit contrast agent to another molecule with differing side-chains is more effective than premedication.
Original languageEnglish
Article number13
Pages (from-to)6811-6825
Number of pages15
JournalEuropean radiology
Volume35
Issue number11
Early online date2025
DOIs
Publication statusPublished - Nov 2025
Externally publishedYes

Keywords

  • Contrast media
  • Hypersensitivity
  • Practice guideline
  • Prevention
  • Recurrence

Fingerprint

Dive into the research topics of 'Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee'. Together they form a unique fingerprint.

Cite this